Literature DB >> 12106843

The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations.

Frank M Sacks1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12106843     DOI: 10.1016/s0002-9149(02)02436-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  44 in total

Review 1.  Lipid lowering to delay the progression of coronary artery disease.

Authors:  Michael D Feher
Journal:  Heart       Date:  2003-04       Impact factor: 5.994

Review 2.  Toxicity of antilipidemic agents: facts and fictions.

Authors:  Antonios M Xydakis; Peter H Jones
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

Review 3.  Reverse cholesterol transport: high-density lipoprotein's magnificent mile.

Authors:  Peter P Toth
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

Review 4.  Addressing cardiovascular risk beyond low-density lipoprotein cholesterol: the high-density lipoprotein cholesterol story.

Authors:  Emma A Meagher
Journal:  Curr Cardiol Rep       Date:  2004-11       Impact factor: 2.931

5.  JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.

Authors: 
Journal:  Heart       Date:  2005-12       Impact factor: 5.994

Review 6.  Best practice in primary care pathology: review 7.

Authors:  W S A Smellie; J Forth; S R S Smart; M J Galloway; W Irving; D Bareford; P O Collinson; K G Kerr; G Summerfield; P J Carey; Rubin Minhas
Journal:  J Clin Pathol       Date:  2006-10-17       Impact factor: 3.411

7.  Effect of Hoodia gordonii meal supplementation at finisher stage on productivity and carcass characteristics of Ross 308 broiler chickens.

Authors:  T D Mohlapo; J W Ng'ambi; D Norris; M M Malatje
Journal:  Trop Anim Health Prod       Date:  2009-04-26       Impact factor: 1.559

Review 8.  Lipid abnormalities in the metabolic syndrome.

Authors:  Eliot A Brinton
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

9.  Atorvastatin decreases triacylglycerol-associated risk of vascular events in coronary heart disease patients.

Authors:  Vasilios G Athyros; Anna I Kakafika; Athanasios A Papageorgiou; Konstantinos Tziomalos; Athanasios Skaperdas; Efstathios Pagourelias; Athina Pirpasopoulou; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  Lipids       Date:  2007-08-23       Impact factor: 1.880

Review 10.  Inhibition of cholesteryl ester transfer protein activity: a new therapeutic approach to raising high-density lipoprotein.

Authors:  Daniel J Rader
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.